Skip to main content
Equibles
MCK logo

MCK · Mckesson Corp · Metrics

Track MCK — free

Use MCK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MCK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1,015.50 -14.62 (-1.42%) At close · Oct 21
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$120.10B
Shares
116.59M
Volume · Oct 21 772.93K Avg daily vol (3M) 895.18K

MCK metrics

108 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1,015.50
Market cap
$120.10B

Price action

20 metrics
Price change (1W)
+4.0%
Price change (30D)
+13.9%
Price change (3M)
+24.7%
Price change (6M)
+22.5%
Price change (YTD)
+23.8%
Price change (1Y)
+29.0%
Trailing year
Price change (5Y)
+390.1%
52-week high
$1,030.12
52-week low
$725.17
Change from 52-week high
-1.4%
Change from 52-week low
+40.0%
Annualized volatility
31.0%
Annualized volatility (3M)
30.1%
Beta
-0.3
RSI (14D)
72.7
Price vs SMA 50
+12.3%
Price vs SMA 200
+18.5%
Avg volume (3M)
895,175
Relative volume
0.9
Average dollar volume
$797.14M

Company

3 metrics
Sector
Healthcare
Industry
Medical Distribution
Shares outstanding
116.59M

Valuation

12 metrics
P / E (TTM)
27.2
Trailing earnings · reciprocal yield 3.7%
PEG ratio
—
EV / revenue
0.3×
reciprocal yield 329.7%
EV / EBITDA
18.3×
reciprocal yield 5.5%
EV / EBIT
19.2×
reciprocal yield 5.2%
P / sales
0.3×
reciprocal yield 342.2%
P / book
—
FCF yield
5.3%
TTM · current market cap
Buyback yield
5.6%
P / FCF
18.7
reciprocal yield 5.3%
P / operating cash flow
17.5
reciprocal yield 5.7%
Earnings yield
3.8%

Historical valuation

8 metrics
P / E historical average (3Y)
24.9×
reciprocal yield 4.0%
P / E historical average (5Y)
25.6×
reciprocal yield 3.9%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 409.6%
EV / revenue historical average (5Y)
0.2×
reciprocal yield 458.5%
EV / EBIT historical average (3Y)
18.9×
reciprocal yield 5.3%
EV / EBIT historical average (5Y)
18.3×
reciprocal yield 5.5%
EV / EBITDA historical average (3Y)
16.3×
reciprocal yield 6.2%
EV / EBITDA historical average (5Y)
16.3×
reciprocal yield 6.2%

Dividends & buybacks

7 metrics
Dividend yield
0.3%
Trailing 12 months
Payout ratio
8.6%
Shareholder yield
5.9%
Dividend / share (TTM)
$3.40
Dividend growth YoY
+15.3%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-01

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
3.6%
Operating margin
1.6%
Trailing 12 months
Net margin
1.1%
Gross profit (TTM)
$14.96B
Operating profit (TTM)
$6.50B
Net income (TTM)
$4.59B
Trailing 12 months
Diluted EPS (TTM)
$37.28
FCF margin
1.6%
Effective tax rate
17.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$3,355.68
Gross profit per diluted share (TTM)
$122.11
Operating profit per diluted share (TTM)
$52.97
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$37.36
Operating cash flow per diluted share (TTM)
$55.43
Free cash flow per diluted share (TTM)
$51.86
Capital expenditures per diluted share (TTM)
$3.57
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-23.77

Growth

11 metrics
Revenue growth YoY
+7.7%
Year over year
Net income growth YoY
-21.7%
Revenue (TTM)
$410.98B
Trailing 12 months
EPS growth YoY
-17.6%
Shares change YoY
-5.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+13.4%
Revenue CAGR (5Y)
+11.1%
EPS CAGR (3Y)
+15.3%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+6.2%
FCF CAGR (5Y)
+6.9%

Quality

14 metrics
Return on equity
—
Return on assets
5.2%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
$6.82B
Free cash flow (TTM)
$6.42B
Quick ratio
0.5
Interest coverage
23.6
Net debt / EBITDA
0.7
Return on invested capital
1,800.8%
Trailing 12 months
Net cash
−$4.54B
Latest balance sheet
Cash & equivalents
$5.16B
Total assets
$88.33B
Total debt
$9.70B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$6.85B
Capital expenditures (TTM)
$437.00M
R&D (TTM)
—
SG&A (TTM)
$8.16B
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
2,032
13F filer change QoQ
-27
Institutional ownership
91.3%
Conviction holders (share of 13F filers)
1.4%
Crowding (high-turnover and private-fund holders)
16.9%
Private-fund adviser ownership
15.2%
Active holders' share change QoQ
-8.1%
Holder tenure
18.5
Price vs estimated holder cost
+12.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
18.8%

Short interest

3 metrics
Short interest
2.0%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.16M
Insider-sentiment score
53 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 927653 CUSIP 58155Q103 13F (30d) 518 filings 481 filers Visit website Investor relations